News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

British Vaccine Firm Microscience Joins IPO Wave; $71.6 Million


10/19/2005 5:11:29 PM

A British biotechnology company developing a drinkable vaccine against the most common cause of traveller's diarrhoea is planning to raise 40 million pounds ($71.6 million) through an IPO next month.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES